The Europe miRNA sequencing and assay market is expected to reach US$ 144.87 million by 2027 from US$ 62.30 million in 2019; it is estimated to grow at a CAGR of 11.3% from 2020 to 2027.
The widening application range of microRNAs and rise in funding for genomics research. However, challenges associated with the delivery, efficacy, and specificity of miRNA-based therapeutics hinder the market growth.
MicroRNAs (miRNAs) are noncoding RNAs that are partially complementary to messenger RNA (mRNA). They are known to downregulate the expression, which makes them vital regulators of important cellular functions. Being involved in the process of differentiation, they act as markers in cell type identification. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs. Furthermore, new discoveries regarding the role of miRNAs in disease development have made them a key target of novel therapeutic approaches. Several miRNA-targeted therapeutics against the diseases such as cancer and hepatitis have reached the clinical phase. For instance, Santaris Pharma has developed a therapeutic molecule named Miravirsen that targets miR-122 for the treatment of hepatitis C virus (HCV) infection; the molecule is in the Phase II clinical trial. Therefore, rise in funding of genomic research to identify new molecules to diagnose and treat diseases, and consequent expansion of the range of applications of miRNAs are driving the growth of the miRNA sequencing and assay market in Europe.
The COVID-19 pandemic has been having some serious effects on European countries. The miRNA sequencing and assay market in the region witnessed shortfall at the beginning of the pandemic crisis due to disruptions in supply chain and lowered demands due to lockdown imposed by many European countries. However, later, the demand for the miRNA sequencing and assay products increased drastically with supportive government initiatives. Many private research organizations have expanded their research teams and projects to accelerate studies related to SARS-CoV-2. For instance, QIAGEN, Germany, a pioneer in next-generation sequencing (NGS), has expanded its integrated coronavirus next-generation sequencing platforms and software solutions to accelerate COVID-19 research. Hence, the COVID-19 pandemic has been supporting the Europe miRNA sequencing and assay market growth.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe miRNA Sequencing and Assay Market Segmentation
By Product
- Library Preparation
- Consumables
By Technology
- Sequencing by Synthesis
- Nanopore
- Ion Semiconductor Sequencing
By End User
- Research Institute
- Academia
- CRO
By Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Illumina, Inc
- THERMO FISHER SCIENTIFIC INC.
- QIAGEN
- Perkin Elmer, Inc.
- Takara Bio Inc.
- New England Biolabs
- Norgen Biotek Corp
- TriLink BioTechnologies Inc.
- Lexogen GmbH
- Oxford Nanopore Technologies
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Technology, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe miRNA Sequencing and Assay Market – By Product
1.3.2 Europe miRNA Sequencing and Assay Market – By Technology
1.3.3 Europe Global miRNA Sequencing and Assay Market – By End User
1.3.4 Europe miRNA Sequencing and Assay Market – By Country
2. miRNA Sequencing and Assay Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe miRNA Sequencing and Assay – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe – PEST Analysis
4.3 Expert Opinions
5. miRNA Sequencing and Assay Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Widening Range of MicroRNA Applications
5.1.2 Rise in Funding for Genomics Research
5.2 Market Restraints
5.2.1 Challenges Related to Delivery, Efficacy, and Specificity of miRNA-based Therapeutics
5.3 Market Opportunities
5.3.1 Rising Prevalence of Chronic Conditions and Infectious Diseases
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact analysis
6. miRNA Sequencing and Assay Market – Europe Analysis
6.1 Europe miRNA Sequencing and Assay Market Revenue Forecast and Analysis
7. miRNA Sequencing and Assay Market Analysis – By Product
7.1 Overview
7.2 miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)
7.3 Library Preparation
7.3.1 Overview
7.3.2 Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Consumables
7.4.1 Overview
7.4.2 Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8. miRNA Sequencing and Assay Market Analysis – By Technology
8.1 Overview
8.2 miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027, (%)
8.3 Sequencing by Synthesis
8.3.1 Overview
8.3.2 Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Nanopore
8.4.1 Overview
8.4.2 Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Ion Semiconductor Sequencing
8.5.1 Overview
8.5.2 Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9. miRNA Sequencing and Assay Market Analysis – By End User
9.1 Overview
9.2 miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027, (%)
9.3 Research Institute
9.3.1 Overview
9.3.2 Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Academia
9.4.1 Overview
9.4.2 Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Contract Research Organizations (CROs)
9.5.1 Overview
9.5.2 Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
10. miRNA Sequencing and Assay Market – Europe Analysis
10.1 Europe: miRNA Sequencing and Assay Market
10.1.1 Overview
10.1.2 Europe: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)
10.1.3 Germany: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.1 Germany: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.3.2 Germany miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.3.3 Germany miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.3.4 Germany miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.4 UK: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.1 UK: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.4.2 UK miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.4.3 UK miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.4.4 UK miRNA Sequencing and Assay Market, by End User– Revenue and Forecast to 2027 (USD Million)
10.1.5 France: Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.1 France: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.5.2 France miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.5.3 France miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.5.4 France miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 Spain: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 Spain: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.2 Spain miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.6.3 Spain miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.6.4 Spain miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.7 Italy: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Italy: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Italy miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Italy miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Italy miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 Rest of Europe: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Rest of Europe: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Rest of Europe miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Rest of Europe miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Rest of Europe miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Europe miRNA Sequencing and Assay Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Illumina, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 QIAGEN
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Perkin Elmer, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Takara Bio Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 New England Biolabs
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Norgen Biotek Corp
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 TriLink BioTechnologies Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lexogen GmbH
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Oxford Nanopore Technologies
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. Germany miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 3. Germany miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. UK miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. UK miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 6. UK: miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million).
Table 7. France miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. France miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 9. France miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Spain miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Spain miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 12. Spain miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Italy miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Italy miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 15. Italy miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Rest of Europe miRNA Sequencing and Assay Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 17. Rest of Europe miRNA Sequencing and Assay Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 18. Rest of Europe miRNA Sequencing and Assay Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. Organic Developments Done by Companies
Table 20. Inorganic Developments Done by Companies
Table 21. Glossary of Terms, miRNA Sequencing and Assay Market
LIST OF FIGURES
Figure 1. miRNA Sequencing and Assay Market Segmentation
Figure 2. miRNA Sequencing and Assay Market Segmentation, By Country
Figure 3. miRNA Sequencing and Assay Market Overview
Figure 4. Library Preparation Segment by Product Segment Expected to Witness Rapid Growth
Figure 5. Europe miRNA Sequencing and Assay Market – Leading Country Markets (US$ Million)
Figure 6. Europe PEST Analysis
Figure 7. miRNA Sequencing and Assay Market Impact Analysis of Driver and Restraints
Figure 8. Europe miRNA Sequencing and Assay Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. miRNA Sequencing and Assay Market Revenue Share, by Product (2019 and 2027)
Figure 10. Library Preparation: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Consumables: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. miRNA Sequencing and Assay Market Share, by Technology, 2019 and 2027 (%)
Figure 13. Sequencing by Synthesis: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Nanopore: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Ion Semiconductor Sequencing: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. miRNA Sequencing and Assay Market Share, by End User, 2019 and 2027 (%)
Figure 17. Research Institute: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Academia: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 19. Contract Research Organizations (CROs): miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Europe: miRNA Sequencing and Assay Market, by Key Country – Revenue (2019) (USD Million)
Figure 21. Europe: miRNA Sequencing and Assay Market, by Country, 2019 & 2027 (%)
Figure 22. Germany: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. UK: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. France: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. Spain: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Italy: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Rest of Europe: miRNA Sequencing and Assay Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic in European Country Markets
The List of Companies - Europe miRNA Sequencing and Assay Market
- Illumina, Inc
- THERMO FISHER SCIENTIFIC INC.
- QIAGEN
- Perkin Elmer, Inc.
- Takara Bio Inc.
- New England Biolabs
- Norgen Biotek Corp
- TriLink BioTechnologies Inc.
- Lexogen GmbH
- Oxford Nanopore Technologies
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe miRNA Sequencing and Assay Market
May 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
May 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
May 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
May 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
May 2021